Dr Paul Sinclair Dr Ruth Cranston Prahlad Raninga Joanna Cheng Rebecca Hanna et al. | Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia | 2023 |
|
Claire Schwab Dr Ruth Cranston Dr Sarra Ryan Ellie Butler Emily Winterman et al. | Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial | 2023 |
|
Sarra Ryan Dr Ruth Cranston Claire Schwab Dr Matthew Bashton Dr Paul Sinclair et al. | The genomic landscape of acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 | 2023 |
|
Sarra Ryan Claire Schwab Dr Richard Yim Dr Ruth Cranston Dr Lisa Russell et al. | Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia | 2023 |
|
Claire Schwab Daniel Murdy Ellie Butler Dr Amir Enshaei Emily Winterman et al. | Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification | 2022 |
|
Dr Paul Sinclair Dr Sarra Ryan Dr Matthew Bashton Shaun Hollern Rebecca Hanna et al. | SH2B3 inactivation through CN-LOH-12q is uniquely associated with B-cell precursor ALL with iAMP21 or other chromosome 21 gain | 2019 |
|
Dr Ruth Cranston Dr Paul Sinclair Dr Matthew Bashton Dr Matthew Selby Professor Christine Harrison FRCPath FMedSci et al. | A Genome-Wide CRISPR Screen Implicates MYC Dysregulation in TCF3-PBX1 B-ALL | 2018 |
|
Dr Martina Finetti Matthew Selby Dr Matthew Bashton Dr Ruth Cranston Dr Stephen Crosier et al. | Integrated pathway analysis of malignant rhabdoid tumour identifies key SMARCB1-pathways and therapeutic opportunities | 2016 |
|
Matthew Selby Dr Martina Finetti Dr Matthew Bashton Dr Ruth Cranston Alicia Del Carpio Pons et al. | Investigating the biology of atypical teratoid/rhabdoid tumors by whole genome CRISPR/CAS9 screening | 2016 |
|